Skip to main content

Table 4 Binary and multivariable logistic regression of factors associated with H. pylori eradication in the hospitals in Hawassa city, February–June 2023 (n = 291)

From: Prevalence of Helicobacter pylori infection and effectiveness of first-line triple eradication therapy among dyspeptic patients at hospitals in Hawassa City, Ethiopia: a cross-sectional follow-up study

Variable

Category

FAT after HPET

COR (CI: 95%)

P-value

AOR (CI: 95%)

P-value

Positive

Negative

Sex

Male

15

79

–

   

Female

32

165

1.02 (0.52,1.99)

   

Age (years)

18–24

14

65

    

25–34

12

93

0.59 (0.26, 1.38)

0.23

  

35–44

8

44

0.84 (0.33, 2.18)

0.73

  

45–54

6

24

1.16 (0.4, 3.37)

0.78

  

> 54

7

18

1.81 (0.63, 5.14)

0.27

  

Residence

Urban

16

146

–

   

Rural

31

98

2.89 (1.49, 5.56)

0.002

0.50 (0.22, 1.16)

0.106

Educational status

Illiterate

4

30

–

   

Primary school

7

25

2.1 (0.55, 8.01)

0.28

  

Secondary school

23

60

2.88 (0.91, 9.07)

0.07

1.88 (0.41, 8.71)

0.42

College and above

13

129

0.76 (0.23, 2.48)

0.64

  

History of gastritis

No

19

99

–

   

Yes

28

145

1.01(0.53, 1.90)

0.98

  

History of H. pylori status

Not known

23

106

–

   

Positive

15

32

2.16 (1.01, 4.63)

0.04

1.21 (0.36, 4.02)

0.75

Negative

9

106

0.39 (0.17, 0.89)

0.02

0.81 (0.31, 2.09)

0.65

History of eradication therapy

No

33

228

–

   

Yes

14

16

6.05 (2.70, 13.52)

0.001

4.82 (1.37, 16.97)

0.014

Duration of illness

Less than a month

12

80

–

   

More than a month

35

164

1.42 (0.70, 2.88)

0.33

  

History of other illnesses

No

28

154

–

   

Yes

19

90

1.16 (0.61, 2.20)

0.65

  

History of alcohol intake

No

8

38

–

   

Yes

39

206

0.89 (0.39, 2.07)

0.8

  

History traditional medicine use

No

37

219

–

   

Yes

10

25

2.37 (1.05, 5.33)

0.037

1.74 (0.64, 4.71)

0.27

Eradication regimen used

OAC for 14-days

32

232

–

   

OAC for 10-days

8

12

3.96 (1.52, 10.32)

0.005

4.05 (1.42, 11.55)

0.009*

Regimen completeness

Complete

22

185

–

   

Incomplete

25

59

3.56 (1.87, 6.78)

0

1.34 (0.59, 2.99)

0.47

Adverse effect self-report

Present

36

107

–

   

Absent

11

137

4.19 (2.04, 8.62)

0

2.58 (1.12, 5.97)

0.026*

Adherence

Adhered

35

195

    

Not-adhered

12

49

0.73 (0.35, 1.52)

0.402

–

–

  1. OAC Omeprazole Amoxicillin Clarithromycin, COR Crude Odds Ratio, AOR Adjusted Odds Ratio, FAT Fecal Antigen Test, HPET H. pylori Eradication Therapy
  2. *Significant